Hims & Hers Health (HIMS) stock moves a notch higher Monday morning after the company's weight-loss drug ad played during the Super Bowl. The commercial's airing raised concerns from health ...

The telehealth company is being criticized for its Super Bowl weight loss commercial. (Hims & Hers via YouTube) ...

Hims & Hers is under fire over an ad for its weight loss offerings that's slated to run during the Super Bowl on Sunday. Two U.S. senators expressed concern over an "upcoming advertisement" that ...

Shares of Hims & Hers Health Inc. jumped nearly 4% in early premarket trading Monday, on track for fresh record highs, after the company aired a provocative Super Bowl ad that targeted Big Pharma ...

Drug industry groups took issue with the ad in the days leading up to the Super Bowl, asking the Food and Drug Administration to "take action" and "protect Americans from misleading markets." In a ...

Hims & Hers Health has undeniably captured market attention and investor enthusiasm, fueled by a successful Super Bowl ad campaign and its strategic entry into the high-demand GLP-1 weight loss ...

Telehealth company Hims & Hers has had enough—and is putting its money where its mouth is in the form of its first Super Bowl ad, called “Sick of the System.” The minute-long commercial is ...

Telehealth stock Hims & Hers (HIMS) spiked more than 24% in trading Thursday, days after its Super Bowl ad promoting cheaper GLP-1 weight-loss drugs sparked controversy. The ad criticized the ...

Hims & Hers revealed that it will make its Big Game debut with a minute-long ad highlighting its compounded GLP-1 weight loss drug offerings. Set to Childish Gambino’s 2018 hit song “This Is America,” ...